Understanding and Avoiding Compliance Errors
Know where labs may fall foul of compliance requirements—and discover the actions your lab can take to mitigate the risk of noncompliance
Keeps You Up-to-Date on Federal & State Laws, Regulations, New Legislation, and Court Cases that Affect Your Diagnostic Lab or Pathology Practice
Know where labs may fall foul of compliance requirements—and discover the actions your lab can take to mitigate the risk of noncompliance
Despite Congress’ clear policy on private insurer payment of COVID-19 tests, many labs have been struggling to get reimbursed.
Though Congress didn’t pass VALID as part of the medical devices user fees bill, there’s still a good chance it will pass before year’s end.
Sentencing has been postponed for one month to explore possible government mishandling of key witness testimony.
What you need to know about the 308-page proposed rule and its potential impact on your lab, along with a basic strategy to implement it.
The problems began in January 2020 when hackers got access to an employee’s email account, compromising clients’ personal data.
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
After the price transparency rules took effect in January 2021, CMS finally issued the first penalties for violations.
CMS has instructed its MACs to recognize eight new CLIA-waived complexity tests for which labs will be allowed to bill, effective Oct. 1.
Mark Schena was convicted of swindling investors and running a $77 million kickback scheme involving COVID-19 and allergy tests.
Biden administration blames the decision on Congress’ failure to provide the additional funding necessary to keep the program going.